Shares of USA-based Intra-Cellular Therapies leapt almost 36% to $128.85 in pre-marker activity today, as rumors of a ...

CNX Therapeutics partners with Klaria Pharma to market sumatriptan alginate film in Europe, addressing critical migraine ...

Aragen Life Sciences secures $100M investment from Quadria Capital, valuing the CRDMO at $1.4B. The funding supports ...

China's top drug regulator has recently approved the nation's first stem cell therapy to treat a type of complication ...

AbbVie records a $3.5 billion impairment charge following the failure of emraclidine in Phase II schizophrenia trials.

US biopharma Biohaven and Dutch biotech Merus have announced a research collaboration and license agreement to co-develop ...

New export figures for November from Statistics Denmark show that medicine constitutes a significant part of total Danish ...

City Therapeutics partners with Bausch + Lomb to develop an RNAi-based therapy for geographic atrophy, leveraging City’s RNAi ...

Gilead Sciences and Danish dermatology specialist LEO Pharma announced a strategic partnership, marking another move outside ...

Teva partners with Klinge Biopharma and Formycon to commercialize FYB203, an Eylea biosimilar, as Ahzantive in Europe and ...

Real-world evidence (RWE) specialist Atropos Health has announced a collaboration with US pharma giant Merck & Co.

A clinical-stage biopharma company focused on developing therapies for obesity and other cardiometabolic disorders.